|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1400 AUD | +3.70% |
|
+3.70% | -6.67% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 71.86 | - |
| Change | - | - | 343.99% | -40.4% | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 56.36 | 50.36 |
| Change | - | - | 241.42% | -39.21% | -10.65% |
| P/E | -2.64x | -3.27x | -14.3x | -6.09x | -23.3x |
| PBR | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.2x | 0.3x |
| Capitalization / Revenue | - | - | - | - | 7.19x |
| EV / Revenue | - | - | - | - | 5.04x |
| EV / EBITDA | - | - | -11.2x | -4.9x | -14.4x |
| EV / EBIT | - | - | -11.1x | -4.86x | -14x |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.006 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 10 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -3.5 |
| EBIT 1 | - | - | -8.389 | -11.6 | -3.6 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -3.6 |
| Net Debt 1 | - | - | -27.85 | -15.5 | -21.5 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1400 | 0.1400 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - |
| Announcement Date | 30/05/23 | 30/05/25 | 29/05/26 | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.09x | - | -4.9x | - | 50.25M | |
| 33.56x | 8.36x | 25.84x | 0.05% | 57.28B | |
| 20.68x | 6.37x | 13.94x | 1.54% | 54.99B | |
| -41.86x | 13.29x | -39.17x | -.--% | 23.18B | |
| -17.88x | 4.15x | -7.26x | -.--% | 22.59B | |
| 25.74x | 5.04x | 13.35x | -.--% | 20.46B | |
| 24.54x | 4.77x | 15.5x | -.--% | 17.56B | |
| -523.64x | 37.41x | -1539.29x | -.--% | 15.67B | |
| 43.58x | 17.61x | 45.34x | 0.08% | 14.46B | |
| 17.42x | 5.04x | 11.77x | -.--% | 13.92B | |
| Average | -42.40x | 11.34x | -146.49x | 0.19% | 24.01B | |
| Weighted average by Cap. | -19.52x | 9.70x | -89.84x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
